Table 1. Clinical characteristics of all patients with nonsurgical hypoparathyroidism from 2005 through 2015 (n = 897).

Variable	Number (% or range)a
Female sex	529 (59%)
Age at baseline, years, mean (SD)	43.8 (21.9)
Diagnosis (code), n (%)
DiGeorge syndrome (D82.1)	36 (4.0%)
Autoimmune polyglandular failure (E31.0)	1 (0.1%)
Idiopathic or unspecified hypoparathyroidism (E20.0, E20.8, E20.9)	860 (95.9%)
Medication, median dose (min-max)
Vitamin D analogs, μg/day
Calcitriol only (n = 482)	0.25 (0.25–1.0)
Alfacalcidol only (n = 259)	0.5 (0.5–2.0)
Calcifediol only (n = 6)	20 (20–20)
Mixed (n = 150)	NE
Calcium supplements
Elemental dose, mg/day	207 (100–1487)
Complications at baseline, n (%)	393 (43.8%)
Cardiovascular disease	139 (15.5%)
Renal stones	9 (1.0%)
Seizures	148 (16.5%)
Cataract	100 (11.2%)
Depression and bipolar disease	125 (13.9%)
Fracture	25 (2.8%)
Intracranial calcification	4 (0.5%)

NE, not evaluable.